# Abfero Pharmaceuticals, Inc. — Form D/A

Abfero Pharmaceuticals, Inc. of LEXINGTON, MA, a company, filed a Form D amendment with the SEC on 2019-04-11. The offering totals $1.0M, of which $600K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-04-11
- Form: D/A
- Accession: 0001769029-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $600K
- Remaining: $400K
- Minimum investment: $50K
- Investors: 6
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-333743

## Issuer

- Name: Abfero Pharmaceuticals, Inc.
- CIK: 0001769029
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2016
- Address: 405 WALTHAM STREET SUITE 353, LEXINGTON, MA, 02421
- Phone: 7812667297

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Steven Burke | Related Person | Lexington, MA |
| Thomas X. Neenan | Related Person | Lexington, MA |
| Michael Penington | Related Person | Lexington, MA |
| Michael X Penington | Director | Boston, MA |
| Thomas X Neenan | Director | Boston, MA |
| Thomas X Neenan | Executive Officer | Boston, MA |
| Steven X Burke | Director | Boston, MA |
| Steven X Burke | Executive Officer | Boston, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-03-23](https://search.stillhousedata.com/formd/0001769029-21-000002) | D | $1.0M | $500K |
| [2020-06-24](https://search.stillhousedata.com/formd/0001769029-20-000002) | D | $2.0M | $680K |
| [2019-02-27](https://search.stillhousedata.com/formd/0001769029-19-000001) | D | $1.0M | $300K |

## More

- [CIK 1769029 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1769029&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001769029-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.